drugset / Trial / NCT06095115
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.
Timeline
- Start
- 2023-10-12
- Primary completion
- 2024-07-29
- Completion
- 2027-04-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icotrokinra | Peptide | 200 mg | Oral |